Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Accelerate Diagnostics, Inc Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$81.3 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.54 - $1.41 $41,507 - $108,381	-76,866 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$4.27 - $6.97 $98,414 - $160,644	23,048 Added 42.83%	76,866 $396,000
Q3 2021 Nov 04, 2021	SELL	$5.31 - $8.25 $23,109 - $35,904	-4,352 Reduced 7.48%	53,818 $314,000
Q2 2021 Aug 06, 2021	BUY	$6.81 - $9.23 $100,835 - $136,668	14,807 Added 34.15%	58,170 $469,000
Q1 2021 May 06, 2021	BUY	$7.99 - $15.0 $121,759 - $228,585	15,239 Added 54.19%	43,363 $361,000
Q4 2020 Feb 09, 2021	BUY	$7.04 - $11.7 $1,133 - $1,883	161 Added 0.58%	28,124 $213,000
Q3 2020 Nov 10, 2020	SELL	$9.98 - $18.04 $84,370 - $152,510	-8,454 Reduced 23.21%	27,963 $298,000
Q2 2020 Aug 06, 2020	BUY	$7.49 - $15.16 $136,872 - $277,033	18,274 Added 100.72%	36,417 $552,000
Q1 2020 May 11, 2020	BUY	$4.62 - $18.74 $15,477 - $62,778	3,350 Added 22.65%	18,143 $151,000
Q4 2019 Feb 05, 2020	BUY	$14.6 - $18.13 $34,222 - $42,496	2,344 Added 18.83%	14,793 $252,000
Q3 2019 Nov 12, 2019	BUY	$16.62 - $23.92 $14,874 - $21,408	895 Added 7.75%	12,449 $231,000
Q2 2019 Aug 08, 2019	SELL	$17.79 - $22.88 $50,488 - $64,933	-2,838 Reduced 19.72%	11,554 $264,000
Q1 2019 Apr 26, 2019	BUY	$11.76 - $22.15 $9,831 - $18,517	836 Added 6.17%	14,392 $303,000
Q4 2018 Feb 08, 2019	BUY	$10.42 - $21.94 $63,707 - $134,141	6,114 Added 82.16%	13,556 $159,000
Q3 2018 Nov 13, 2018	BUY	$20.4 - $24.6 $151,816 - $183,073	7,442 New	7,442 $171,000

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account